The control and prevention of type 2 diabetes by the inhibition of adipose tissue inflammation through Diacerei
Not Applicable
Completed
- Conditions
- Patients aged 40â€65 years who had type 2 Diabetes for at least 2 years since diagnosis with a glycated haemoglobin (HbA1c) level of 7.5%â€10%type 2 Diabetes who had inadequate glycaemic control
- Registration Number
- TCTR20200820004
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Type 2 Diabetes for at least 2 years since diagnosis with a glycated haemoglobin (HbA1c) level of 7.5%â€10%
Exclusion Criteria
Patients who had chronic inflammatory disease, chronic steroid use, serum creatinine level >2 mg/dL or eGFR <60 ml/min/1.73 m2/day, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels more than three times the upper normal limit
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncont 2 year performance liquid chromatography coupled to an accurate-mass quadrupole time-of-flight mass spectro,Metabolic biomarkers for coronary artery disease in inadequately controlled type 2 Diabetes 2 year performance liquid chromatography coupled to an Agilent 6540 UHD accurate-mass quadrupole time-of-fl,The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncont 2 year performance liquid chromatography coupled to an Agilent 6540 UHD accurate-mass quadrupole time-of-fl,The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncont 2 year performance liquid chromatography coupled to an Agilent 6540 UHD accurate-mass quadrupole time-of-fl
- Secondary Outcome Measures
Name Time Method none none none